BioNTech looking into taking legal steps against CureVac




  • In US
  • 2022-07-06 13:24:27Z
  • By Reuters
 

BERLIN (Reuters) - BioNTech is looking into taking legal steps against CureVac after the latter filed a patent lawsuit against it over its use of mRNA technology, BioNTech said on Wednesday, confirming a report by daily Welt.

"We are looking at all legal options," said a BioNTech spokesperson.

CureVac is seeking "fair compensation" from BioNTech and two subsidiaries for infringement of its intellectual property rights, it said on Tuesday.

BioNTech has said in reaction that its work was original and it would defend it against all allegations of patent infringement.

(Reporting by Kirsti Knolle and Patricia Weiss; Editing by Miranda Murray)

COMMENTS

More Related News

BioNTech reports strong first half, expects demand to grow
BioNTech reports strong first half, expects demand to grow
  • US
  • 2022-08-08 13:03:06Z

BioNTech, which teamed with Pfizer to develop a powerful COVID-19 vaccine, has reported higher revenue and net profit in the first half of the year and...

BioNTech expects Omicron-adapted vaccine deliveries as soon as October
BioNTech expects Omicron-adapted vaccine deliveries as soon as October
  • US
  • 2022-08-08 10:22:43Z

BERLIN (Reuters) -BioNTech expects to begin deliveries of two Omicron-adapted vaccines as soon as October, which will help spur demand in the fourth quarter,...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: US